ReachMD

Episodes 1-14 of 14

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Pelin Cinar, MD, MS

    Peer

  • 

    

    Malika Fair, MD, MPH, FACEP

    Peer

  0

  

  RestartResume

  The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities

  1.00 credits

• • 

    

    Timothy Fenske, MD, MS

    Peer

  0

  

  RestartResume

  Part 1: Improving Risk-based Management Decisions in Follicular Lymphoma

  0.50 credits

• • 

    

    Timothy Fenske, MD, MS

    Peer

  0

  

  RestartResume

  Part 2: Improving Risk-based Management Decisions in Follicular Lymphoma

  0.50 credits

• • 

    

    Ruben A. Mesa, MD, FACP

    Peer

  1

  

  RestartResume

  Part 1: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  0.50 credits

• • 

    

    Ruben A. Mesa, MD, FACP

    Peer

  1

  

  RestartResume

  Part 2: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  0.50 credits

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Richard S. Finn, MD

    Peer

  • 

    

    Amit Singal, MD, MS

    Peer

  2

  

  RestartResume

  Multidisciplinary Perspectives in Advanced HCC:  A Focus on Immune Checkpoint Inhibitors

  0.75 credits

• • 

    

    Karen Reckamp, MS, MD

    Peer

  • 

    

    Heather Wakelee, MD

    Peer

  1

  

  RestartResume

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era

  1.00 credits

• • 

    

    Karen Reckamp, MS, MD

    Peer

  • 

    

    Heather Wakelee, MD

    Peer

  5

  

  RestartResume

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series

  0.50 credits

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Hossein Borghaei, MS, DO

    Peer

  5

  

  RestartResume

  Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment

  0.50 credits

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Hossein Borghaei, MS, DO

    Peer

  3

  

  RestartResume

  Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment

  0.50 credits

• • 

    

    Celestia S. Higano, MD

    Peer

  • 

    

    Joaquin Mateo, MD, PhD

    Peer

  • 

    

    Daniel P. Petrylak, MD

    Peer

  10

  

  RestartResume

  Precision Medicine in Advanced Prostate Cancer: A Focus on PARP Inhibitors

  0.50 credits

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Alexander Drilon, MD

    Peer

  4

  

  RestartResume

  Because You Care About Your Patients With ROS1+ NSCLC: Recent Revolutions in Treatment

  0.50 credits

• • 

    

    William D. Tap, MD

    Peer

  7

  

  RestartResume

  Tenosynovial Giant Cell Tumors: Mechanisms for Improving Patient Functionality and Outcomes

  0.50 credits

• • 

    

    Julie Kanter, MD

    Peer

  • 

    

    Foluso “Joy” Ogunsile, MD

    Peer

  5

  

  RestartResume

  Novel Interventions for Preventing & Reducing Pain Crisis in Sickle Cell Disease

  0.50 credits